本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Altimmune, Inc.

3.14
+0.02500.80%
成交量:134.88萬
成交額:429.32萬
市值:6.08億
市盈率:-4.12
高:3.22
開:3.14
低:3.11
收:3.11
52周最高:6.44
52周最低:2.56
股本:1.94億
流通股本:1.64億
量比:0.42
換手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-0.7600
每股收益(LYR):-0.9999
淨資產收益率:-28.87%
總資產收益率:-17.20%
市淨率:1.28
市盈率(LYR):-3.14

資料載入中...

2026/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/28

重要事件披露

Form 8-K - Current report
2026/06/17

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/24

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/02/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/04

重要事件披露

Form 8-K - Current report
2026/01/28

重要事件披露

Form 8-K - Current report